- Home
- CKPT vs CDRO Comparison
CKPT vs CDRO Comparison
Compare CKPT & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- CDRO
- Stock Information
- Founded
- CKPT 2014
- CDRO 2014
- Country
- CKPT United States
- CDRO Luxembourg
- Employees
- CKPT N/A
- CDRO N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- CDRO Services-Misc. Amusement & Recreation
- Sector
- CKPT Health Care
- CDRO Consumer Discretionary
- Exchange
- CKPT Nasdaq
- CDRO Nasdaq
- Market Cap
- CKPT 335.9M
- CDRO 349.8M
- IPO Year
- CKPT 2017
- CDRO N/A
- Fundamental
- Price
- CKPT $4.04
- CDRO $7.10
- Analyst Decision
- CKPT Buy
- CDRO Strong Buy
- Analyst Count
- CKPT 3
- CDRO 2
- Target Price
- CKPT $4.33
- CDRO $10.00
- AVG Volume (30 Days)
- CKPT 1.7M
- CDRO 24.0K
- Earning Date
- CKPT 05-09-2025
- CDRO 05-14-2025
- Dividend Yield
- CKPT N/A
- CDRO N/A
- EPS Growth
- CKPT N/A
- CDRO N/A
- EPS
- CKPT N/A
- CDRO N/A
- Revenue
- CKPT $41,000.00
- CDRO $151,877,729.00
- Revenue This Year
- CKPT $102,182.93
- CDRO $37.91
- Revenue Next Year
- CKPT $351.71
- CDRO $33.26
- P/E Ratio
- CKPT N/A
- CDRO N/A
- Revenue Growth
- CKPT N/A
- CDRO 51.93
- 52 Week Low
- CKPT $1.38
- CDRO $5.75
- 52 Week High
- CKPT $4.50
- CDRO $8.76
- Technical
- Relative Strength Index (RSI)
- CKPT 63.60
- CDRO 52.14
- Support Level
- CKPT $3.94
- CDRO $5.75
- Resistance Level
- CKPT $4.06
- CDRO $7.15
- Average True Range (ATR)
- CKPT 0.05
- CDRO 0.60
- MACD
- CKPT -0.03
- CDRO 0.05
- Stochastic Oscillator
- CKPT 83.33
- CDRO 76.70
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Italy, Mexico, Colombia, Panama and in the City of Buenos Aires where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. If the user wins, it pays out the bet. If the user loses, it keeps the amount wagered.